Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)
China flag China · Delayed Price · Currency is CNY
27.50
-0.15 (-0.54%)
Feb 4, 2026, 3:00 PM CST

SHA:603351 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
367.35247.2157.5599.8366.2675.56
Trading Asset Securities
3-1.251.1126.24196.71
Cash & Short-Term Investments
370.35247.2158.8100.9392.5272.27
Cash Growth
118.02%55.67%57.33%9.12%-66.03%-47.87%
Accounts Receivable
272.95238.39240.02168.79203.9897.18
Other Receivables
5.394.44.95.852.390.52
Receivables
278.34242.79244.92174.64206.3797.69
Inventory
207.06202.02170.58165.13142.44115.05
Other Current Assets
39.4425.1925.1329.5823.3815.54
Total Current Assets
895.19717.21599.42470.29464.69500.55
Property, Plant & Equipment
1,4331,4491,4991,4821,212940.8
Long-Term Investments
117.6583.4171.2968.794040
Other Intangible Assets
108.9111.9198.3793.5377.4878.49
Long-Term Deferred Tax Assets
4.926.99.255.9811.691.42
Long-Term Deferred Charges
0.920.280.351.332.433.43
Other Long-Term Assets
24.6812.251.2316.5833.4271.72
Total Assets
2,5852,3812,2792,1381,8411,636
Accounts Payable
113.0398.76105.82124.54144.34168.44
Accrued Expenses
25.7534.8131.635.721.1318.74
Short-Term Debt
509.26376.2362.22360.45171.1990.13
Current Portion of Long-Term Debt
11.6950.3911.91.5511.4114.73
Current Portion of Leases
-7.348.777.673.69-
Current Income Taxes Payable
12.474.586.838.440.393.87
Current Unearned Revenue
6.215.47.989.0916.37.73
Other Current Liabilities
18.0818.4322.6232.5854.253.99
Total Current Liabilities
696.49595.9557.75580.02422.7307.63
Long-Term Debt
71.53585.340-11.41
Long-Term Leases
18.8612.3218.7616.3813.6-
Long-Term Unearned Revenue
13.9313.8812.716.56.746
Long-Term Deferred Tax Liabilities
18.5315.6211.712.8512.9811.71
Total Liabilities
819.31672.72686.22655.76456.01336.75
Common Stock
135.44135.44135.44135.48135.48130.67
Additional Paid-In Capital
939.81942.9941.36930.15907.52842.19
Retained Earnings
683.31623.42517.63443.36388.98326.81
Treasury Stock
---12.79-28.7-49.27-
Comprehensive Income & Other
0.550.162.79---
Total Common Equity
1,7591,7021,5841,4801,3831,300
Minority Interest
7.046.278.262.112.71-
Shareholders' Equity
1,7661,7081,5931,4821,3851,300
Total Liabilities & Equity
2,5852,3812,2792,1381,8411,636
Total Debt
611.3481.25486.96426.06199.89116.27
Net Cash (Debt)
-240.96-234.05-328.16-325.13-107.39156
Net Cash Growth
------62.86%
Net Cash Per Share
-1.78-1.73-2.43-2.43-0.811.20
Filing Date Shares Outstanding
135.44135.44135.44135.48135.48130.67
Total Common Shares Outstanding
135.44135.44135.44135.48135.48130.67
Working Capital
198.7121.341.67-109.7442192.92
Book Value Per Share
12.9912.5711.7010.9310.219.95
Tangible Book Value
1,6501,5901,4861,3871,3051,221
Tangible Book Value Per Share
12.1811.7410.9710.249.639.35
Buildings
-570.61426.51276.49213.79129.73
Machinery
-1,167883.91616551.21307.92
Construction In Progress
-128.71494.95835.2643.27680.97
Source: S&P Global Market Intelligence. Standard template. Financial Sources.